cbdMD Inc. (AMEX: YCBD) on June 22, 2022, started off the session at the price of $0.43, soaring 21.30% from the previous trading day. During the day, the shares moved up to $0.62 and dropped to $0.43 before settling in for the closing price of $0.43. Within the past 52 weeks, YCBD’s price has moved between $0.41 and $3.17.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
A company in the Healthcare sector has jumped its sales by 85.40% annually for the last half of the decade. The company achieved an average annual earnings per share of -273.70%. With a float of $40.45 million, this company’s outstanding shares have now reached $58.97 million.
In an organization with 154 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +65.13, operating margin of -44.10, and the pretax margin is -54.61.
cbdMD Inc. (YCBD) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of cbdMD Inc. is 1.30%, while institutional ownership is 17.20%. The most recent insider transaction that took place on Aug 24, was worth 15,096. In this transaction CFO & COO of this company bought 7,400 shares at a rate of $2.04, taking the stock ownership to the 7,400 shares.
cbdMD Inc. (YCBD) Latest Financial update
As on 12/30/2021, Multinational firm has announced its last quarter scores, in which it reported -$0.03 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.04) by $0.01. This company achieved a net margin of -52.60 while generating a return on equity of -25.66. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -273.70% per share during the next fiscal year.
cbdMD Inc. (AMEX: YCBD) Trading Performance Indicators
cbdMD Inc. (YCBD) is currently performing well based on its current performance indicators. A quick ratio of 3.40 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.55 in one year’s time.
Technical Analysis of cbdMD Inc. (YCBD)
Let’s dig in a bit further. During the last 5-days, its volume was 0.52 million. That was better than the volume of 0.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 38.97%. Additionally, its Average True Range was 0.10.
During the past 100 days, cbdMD Inc.’s (YCBD) raw stochastic average was set at 11.98%, which indicates a significant decrease from 44.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 164.55% in the past 14 days, which was higher than the 134.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6452, while its 200-day Moving Average is $1.1869. However, in the short run, cbdMD Inc.’s stock first resistance to watch stands at $0.6143. Second resistance stands at $0.7121. The third major resistance level sits at $0.8041. If the price goes on to break the first support level at $0.4245, it is likely to go to the next support level at $0.3325. The third support level lies at $0.2347 if the price breaches the second support level.
cbdMD Inc. (AMEX: YCBD) Key Stats
Market capitalization of the company is 28.57 million based on 59,357K outstanding shares. Right now, sales total 44,480 K and income totals -23,390 K. The company made 9,630 K in profit during its latest quarter, and -4,660 K in sales during its previous quarter.